APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mealtime Insulin

Compare research editions
View pricing & licenses

Selected research

Industry Research

Mealtime Insulin Industry Research Report 2026

28 December 2025137 pages

Choose your research edition.

Industry ResearchMealtime Insulin Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Mealtime Insulin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Mealtime Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mealtime Insulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mealtime Insulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Mealtime Insulin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Mealtime Insulin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Mealtime Insulin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Mealtime Insulin include Abbott Laboratories, BASF, Biocon Biologics, Gan & Lee Pharmaceuticals, Novo Nordisk, Wockhardt, Bayer, HTBT and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Mealtime Insulin market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Mealtime Insulin Market by Company

Abbott Laboratories

BASF

Biocon Biologics

Gan & Lee Pharmaceuticals

Novo Nordisk

Wockhardt

Bayer

HTBT

Pfizer

Sinovac Biotech

Eli Lilly

Sanofi

Tonghua Dongbao Pharmaceutical

Wanbang Biopharmaceuticals

Zhuhai United Pharmaceutical

Mealtime Insulin Segment by Type

Rapid-acting Insulin Analogs

Short-acting Insulin

Mealtime Insulin Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Mealtime Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mealtime Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mealtime Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mealtime Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Mealtime Insulin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Mealtime Insulin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Mealtime Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mealtime Insulin Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Mealtime Insulin Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Mealtime Insulin Sales Market Share by Manufacturers (2021-2026) Table 8. Global Mealtime Insulin Revenue of Manufacturers (2021-2026) Table 9. Global Mealtime Insulin Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Mealtime Insulin Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Mealtime Insulin Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Mealtime Insulin, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Mealtime Insulin, Product Type & Application Table 14. Global Mealtime Insulin Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Mealtime Insulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Laboratories Company Information Table 19. Abbott Laboratories Business Overview Table 20. Abbott Laboratories Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Abbott Laboratories Mealtime Insulin Product Portfolio Table 22. Abbott Laboratories Recent Developments Table 23. BASF Company Information Table 24. BASF Business Overview Table 25. BASF Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. BASF Mealtime Insulin Product Portfolio Table 27. BASF Recent Developments Table 28. Biocon Biologics Company Information Table 29. Biocon Biologics Business Overview Table 30. Biocon Biologics Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Biocon Biologics Mealtime Insulin Product Portfolio Table 32. Biocon Biologics Recent Developments Table 33. Gan & Lee Pharmaceuticals Company Information Table 34. Gan & Lee Pharmaceuticals Business Overview Table 35. Gan & Lee Pharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio Table 37. Gan & Lee Pharmaceuticals Recent Developments Table 38. Novo Nordisk Company Information Table 39. Novo Nordisk Business Overview Table 40. Novo Nordisk Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Novo Nordisk Mealtime Insulin Product Portfolio Table 42. Novo Nordisk Recent Developments Table 43. Wockhardt Company Information Table 44. Wockhardt Business Overview Table 45. Wockhardt Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Wockhardt Mealtime Insulin Product Portfolio Table 47. Wockhardt Recent Developments Table 48. Bayer Company Information Table 49. Bayer Business Overview Table 50. Bayer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Bayer Mealtime Insulin Product Portfolio Table 52. Bayer Recent Developments Table 53. HTBT Company Information Table 54. HTBT Business Overview Table 55. HTBT Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. HTBT Mealtime Insulin Product Portfolio Table 57. HTBT Recent Developments Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Pfizer Mealtime Insulin Product Portfolio Table 62. Pfizer Recent Developments Table 63. Sinovac Biotech Company Information Table 64. Sinovac Biotech Business Overview Table 65. Sinovac Biotech Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sinovac Biotech Mealtime Insulin Product Portfolio Table 67. Sinovac Biotech Recent Developments Table 68. Eli Lilly Company Information Table 69. Eli Lilly Business Overview Table 70. Eli Lilly Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Eli Lilly Mealtime Insulin Product Portfolio Table 72. Eli Lilly Recent Developments Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Mealtime Insulin Product Portfolio Table 77. Sanofi Recent Developments Table 78. Tonghua Dongbao Pharmaceutical Company Information Table 79. Tonghua Dongbao Pharmaceutical Business Overview Table 80. Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio Table 82. Tonghua Dongbao Pharmaceutical Recent Developments Table 83. Wanbang Biopharmaceuticals Company Information Table 84. Wanbang Biopharmaceuticals Business Overview Table 85. Wanbang Biopharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio Table 87. Wanbang Biopharmaceuticals Recent Developments Table 88. Zhuhai United Pharmaceutical Company Information Table 89. Zhuhai United Pharmaceutical Business Overview Table 90. Zhuhai United Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio Table 92. Zhuhai United Pharmaceutical Recent Developments Table 93. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Mealtime Insulin Sales by Region (2021-2026) & (K Units) Table 95. Global Mealtime Insulin Sales Market Share by Region (2021-2026) Table 96. Global Mealtime Insulin Sales by Region (2027-2032) & (K Units) Table 97. Global Mealtime Insulin Sales Market Share by Region (2027-2032) Table 98. Global Mealtime Insulin Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Mealtime Insulin Revenue Market Share by Region (2021-2026) Table 100. Global Mealtime Insulin Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Mealtime Insulin Revenue Market Share by Region (2027-2032) Table 102. North America Mealtime Insulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 104. North America Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 105. North America Mealtime Insulin Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Mealtime Insulin Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Mealtime Insulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 109. Europe Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 110. Europe Mealtime Insulin Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Mealtime Insulin Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Mealtime Insulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Mealtime Insulin Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Mealtime Insulin Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Mealtime Insulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 119. South America Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 120. South America Mealtime Insulin Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Mealtime Insulin Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Mealtime Insulin Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Mealtime Insulin Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Mealtime Insulin Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Mealtime Insulin Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 128. Global Mealtime Insulin Sales by Type (2027-2032) & (K Units) Table 129. Global Mealtime Insulin Sales Market Share by Type (2021-2026) Table 130. Global Mealtime Insulin Sales Market Share by Type (2027-2032) Table 131. Global Mealtime Insulin Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Mealtime Insulin Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Mealtime Insulin Revenue Market Share by Type (2021-2026) Table 134. Global Mealtime Insulin Revenue Market Share by Type (2027-2032) Table 135. Global Mealtime Insulin Price by Type (2021-2026) & (US$/Unit) Table 136. Global Mealtime Insulin Price by Type (2027-2032) & (US$/Unit) Table 137. Global Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 138. Global Mealtime Insulin Sales by Application (2027-2032) & (K Units) Table 139. Global Mealtime Insulin Sales Market Share by Application (2021-2026) Table 140. Global Mealtime Insulin Sales Market Share by Application (2027-2032) Table 141. Global Mealtime Insulin Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Mealtime Insulin Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Mealtime Insulin Revenue Market Share by Application (2021-2026) Table 144. Global Mealtime Insulin Revenue Market Share by Application (2027-2032) Table 145. Global Mealtime Insulin Price by Application (2021-2026) & (US$/Unit) Table 146. Global Mealtime Insulin Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Mealtime Insulin Distributors List Table 150. Mealtime Insulin Customers List Table 151. Mealtime Insulin Industry Trends Table 152. Mealtime Insulin Industry Drivers Table 153. Mealtime Insulin Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Mealtime Insulin Product Image Figure 5. Global Mealtime Insulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Mealtime Insulin Market Size (2021-2032) & (US$ Million) Figure 7. Global Mealtime Insulin Sales (2021-2032) & (K Units) Figure 8. Global Mealtime Insulin Average Price (US$/Unit) & (2021-2032) Figure 9. Rapid-acting Insulin Analogs Product Image Figure 10. Short-acting Insulin Product Image Figure 11. Hospital and Clinic Product Image Figure 12. Retail Pharmacies Product Image Figure 13. Other Product Image Figure 14. Global Mealtime Insulin Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Mealtime Insulin, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Mealtime Insulin Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Mealtime Insulin Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Mealtime Insulin Sales by Region in 2025 Figure 20. Global Mealtime Insulin Revenue by Region in 2025 Figure 21. North America Mealtime Insulin Market Size by Country in 2025 Figure 22. North America Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 23. North America Mealtime Insulin Revenue Market Share by Country (2021-2032) Figure 24. United States Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Mealtime Insulin Market Size by Country in 2025 Figure 28. Europe Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 29. Europe Mealtime Insulin Revenue Market Share by Country (2021-2032) Figure 30. Germany Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Mealtime Insulin Market Size by Country in 2025 Figure 41. Asia Pacific Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Mealtime Insulin Revenue Market Share by Country (2021-2032) Figure 43. China Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Mealtime Insulin Market Size by Country in 2025 Figure 52. South America Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 53. South America Mealtime Insulin Revenue Market Share by Country (2021-2032) Figure 54. Brazil Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Mealtime Insulin Market Size by Country in 2025 Figure 58. Middle East and Africa Mealtime Insulin Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Mealtime Insulin Revenue Market Share by Country (2021-2032) Figure 60. Egypt Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Mealtime Insulin Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Mealtime Insulin Sales Market Share by Type (2021-2032) Figure 66. Global Mealtime Insulin Revenue Market Share by Type (2021-2032) Figure 67. Global Mealtime Insulin Price (US$/Unit) by Type (2021-2032) Figure 68. Global Mealtime Insulin Sales Market Share by Application (2021-2032) Figure 69. Global Mealtime Insulin Revenue Market Share by Application (2021-2032) Figure 70. Global Mealtime Insulin Price (US$/Unit) by Application (2021-2032) Figure 71. Mealtime Insulin Value Chain Figure 72. Mealtime Insulin Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Mealtime Insulin Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rapid-acting Insulin Analogs
  • Short-acting Insulin
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Abbott Laboratories
  • BASF
  • Biocon Biologics
  • Gan & Lee Pharmaceuticals
  • Novo Nordisk
  • Wockhardt
  • Bayer
  • HTBT
  • Pfizer
  • Sinovac Biotech
  • Eli Lilly
  • Sanofi
  • Tonghua Dongbao Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Zhuhai United Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Mealtime Insulin Market Size (2021-2032)
  4. 2.2.2 Global Mealtime Insulin Sales (2021-2032)
  5. 2.2.3 Global Mealtime Insulin Market Average Price (2021-2032)
  6. 2.3 Mealtime Insulin by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rapid-acting Insulin Analogs
  9. 2.3.3 Short-acting Insulin
  10. 2.4 Mealtime Insulin by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital and Clinic
  13. 2.4.3 Retail Pharmacies
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Mealtime Insulin Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Mealtime Insulin Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Mealtime Insulin Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Mealtime Insulin Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Mealtime Insulin Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Mealtime Insulin, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Mealtime Insulin, Product Type & Application
  8. 3.8 Global Manufacturers of Mealtime Insulin, Established Date
  9. 3.9 Global Mealtime Insulin Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott Laboratories
  2. 4.1.1 Abbott Laboratories Company Information
  3. 4.1.2 Abbott Laboratories Business Overview
  4. 4.1.3 Abbott Laboratories Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Laboratories Mealtime Insulin Product Portfolio
  6. 4.1.5 Abbott Laboratories Recent Developments
  7. 4.2 BASF
  8. 4.2.1 BASF Company Information
  9. 4.2.2 BASF Business Overview
  10. 4.2.3 BASF Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 BASF Mealtime Insulin Product Portfolio
  12. 4.2.5 BASF Recent Developments
  13. 4.3 Biocon Biologics
  14. 4.3.1 Biocon Biologics Company Information
  15. 4.3.2 Biocon Biologics Business Overview
  16. 4.3.3 Biocon Biologics Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Biocon Biologics Mealtime Insulin Product Portfolio
  18. 4.3.5 Biocon Biologics Recent Developments
  19. 4.4 Gan & Lee Pharmaceuticals
  20. 4.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 4.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 4.4.3 Gan & Lee Pharmaceuticals Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio
  24. 4.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 4.5 Novo Nordisk
  26. 4.5.1 Novo Nordisk Company Information
  27. 4.5.2 Novo Nordisk Business Overview
  28. 4.5.3 Novo Nordisk Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Novo Nordisk Mealtime Insulin Product Portfolio
  30. 4.5.5 Novo Nordisk Recent Developments
  31. 4.6 Wockhardt
  32. 4.6.1 Wockhardt Company Information
  33. 4.6.2 Wockhardt Business Overview
  34. 4.6.3 Wockhardt Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Wockhardt Mealtime Insulin Product Portfolio
  36. 4.6.5 Wockhardt Recent Developments
  37. 4.7 Bayer
  38. 4.7.1 Bayer Company Information
  39. 4.7.2 Bayer Business Overview
  40. 4.7.3 Bayer Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Bayer Mealtime Insulin Product Portfolio
  42. 4.7.5 Bayer Recent Developments
  43. 4.8 HTBT
  44. 4.8.1 HTBT Company Information
  45. 4.8.2 HTBT Business Overview
  46. 4.8.3 HTBT Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 HTBT Mealtime Insulin Product Portfolio
  48. 4.8.5 HTBT Recent Developments
  49. 4.9 Pfizer
  50. 4.9.1 Pfizer Company Information
  51. 4.9.2 Pfizer Business Overview
  52. 4.9.3 Pfizer Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Pfizer Mealtime Insulin Product Portfolio
  54. 4.9.5 Pfizer Recent Developments
  55. 4.10 Sinovac Biotech
  56. 4.10.1 Sinovac Biotech Company Information
  57. 4.10.2 Sinovac Biotech Business Overview
  58. 4.10.3 Sinovac Biotech Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sinovac Biotech Mealtime Insulin Product Portfolio
  60. 4.10.5 Sinovac Biotech Recent Developments
  61. 4.11 Eli Lilly
  62. 4.11.1 Eli Lilly Company Information
  63. 4.11.2 Eli Lilly Business Overview
  64. 4.11.3 Eli Lilly Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Eli Lilly Mealtime Insulin Product Portfolio
  66. 4.11.5 Eli Lilly Recent Developments
  67. 4.12 Sanofi
  68. 4.12.1 Sanofi Company Information
  69. 4.12.2 Sanofi Business Overview
  70. 4.12.3 Sanofi Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sanofi Mealtime Insulin Product Portfolio
  72. 4.12.5 Sanofi Recent Developments
  73. 4.13 Tonghua Dongbao Pharmaceutical
  74. 4.13.1 Tonghua Dongbao Pharmaceutical Company Information
  75. 4.13.2 Tonghua Dongbao Pharmaceutical Business Overview
  76. 4.13.3 Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio
  78. 4.13.5 Tonghua Dongbao Pharmaceutical Recent Developments
  79. 4.14 Wanbang Biopharmaceuticals
  80. 4.14.1 Wanbang Biopharmaceuticals Company Information
  81. 4.14.2 Wanbang Biopharmaceuticals Business Overview
  82. 4.14.3 Wanbang Biopharmaceuticals Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio
  84. 4.14.5 Wanbang Biopharmaceuticals Recent Developments
  85. 4.15 Zhuhai United Pharmaceutical
  86. 4.15.1 Zhuhai United Pharmaceutical Company Information
  87. 4.15.2 Zhuhai United Pharmaceutical Business Overview
  88. 4.15.3 Zhuhai United Pharmaceutical Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio
  90. 4.15.5 Zhuhai United Pharmaceutical Recent Developments
5 Global Mealtime Insulin Market Scenario by Region
  1. 5.1 Global Mealtime Insulin Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Mealtime Insulin Sales by Region: 2021-2032
  3. 5.2.1 Global Mealtime Insulin Sales by Region: 2021-2026
  4. 5.2.2 Global Mealtime Insulin Sales by Region: 2027-2032
  5. 5.3 Global Mealtime Insulin Revenue by Region: 2021-2032
  6. 5.3.1 Global Mealtime Insulin Revenue by Region: 2021-2026
  7. 5.3.2 Global Mealtime Insulin Revenue by Region: 2027-2032
  8. 5.4 North America Mealtime Insulin Market Facts & Figures by Country
  9. 5.4.1 North America Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Mealtime Insulin Sales by Country (2021-2032)
  11. 5.4.3 North America Mealtime Insulin Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Mealtime Insulin Market Facts & Figures by Country
  16. 5.5.1 Europe Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Mealtime Insulin Sales by Country (2021-2032)
  18. 5.5.3 Europe Mealtime Insulin Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Mealtime Insulin Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Mealtime Insulin Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Mealtime Insulin Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Mealtime Insulin Market Facts & Figures by Country
  41. 5.7.1 South America Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Mealtime Insulin Sales by Country (2021-2032)
  43. 5.7.3 South America Mealtime Insulin Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Mealtime Insulin Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Mealtime Insulin Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Mealtime Insulin Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Mealtime Insulin Sales by Type (2021-2032)
  2. 6.1.1 Global Mealtime Insulin Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Mealtime Insulin Sales Market Share by Type (2021-2032)
  4. 6.2 Global Mealtime Insulin Revenue by Type (2021-2032)
  5. 6.2.1 Global Mealtime Insulin Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Mealtime Insulin Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Mealtime Insulin Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Mealtime Insulin Sales by Application (2021-2032)
  2. 7.1.1 Global Mealtime Insulin Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Mealtime Insulin Sales Market Share by Application (2021-2032)
  4. 7.2 Global Mealtime Insulin Revenue by Application (2021-2032)
  5. 7.2.1 Global Mealtime Insulin Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Mealtime Insulin Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Mealtime Insulin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Mealtime Insulin Value Chain Analysis
  2. 8.1.1 Mealtime Insulin Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Mealtime Insulin Production Mode & Process
  5. 8.2 Mealtime Insulin Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Mealtime Insulin Distributors
  8. 8.2.3 Mealtime Insulin Customers
9 Global Mealtime Insulin Analyzing Market Dynamics
  1. 9.1 Mealtime Insulin Industry Trends
  2. 9.2 Mealtime Insulin Industry Drivers
  3. 9.3 Mealtime Insulin Industry Opportunities and Challenges
  4. 9.4 Mealtime Insulin Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst